help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katznelson, L.
Right arrow Articles by Klibanski, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katznelson, L.
Right arrow Articles by Klibanski, A.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4358-4365, Copyright © 1996 by Endocrine Society

ARTICLES

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism

L Katznelson, JS Finkelstein, DA Schoenfeld, DI Rosenthal, EJ Anderson and A Klibanski
Neuroendocrine Unit, Massachusetts General Hospital, Boston 02114, USA.

Acquired hypogonadism is being increasingly recognized in adult men. However, the effects of long term testosterone replacement on bone density and body composition are largely unknown. We investigated 36 adult men with acquired hypogonadism (age, 22-69 yr; median, 58 yr), including 29 men with central hypogonadism and 7 men with primary hypogonadism, and 44 age-matched eugonadal controls. Baseline evaluation included body composition analysis by bioimpedance, determination of site-specific adipose area by dual energy quantitative computed tomography scan (QCT) of the lumbar spine, and measurements of spinal bone mineral density (BMD) using dual energy x-ray absortiometry, spinal trabecular BMD with QCT, and radial BMD with single photon absorptiometry. Percent body fat was significantly greater in the hypogonadal men compared to eugonadal men (mean +/- SEM, 26.4 +/- 1.1% vs. 19.2 +/- 0.8%; P < 0.01). The mean trabecular BMD determined by QCT for the hypogonadal men was 115 +/- 6 mg K2HPO4/cc. Spinal BMD was significantly lower than that in eugonadal controls (1.006 +/- 0.024 vs. 1.109 +/- 0.028 g/cm2; P = 0.02, respectively). Radial BMD was similar in both groups. Testosterone enanthate therapy was initiated in 29 hypogonadal men at a dose of 100 mg/week, and the subjects were evaluated at 6-month intervals for 18 months. During testosterone therapy, the percent body fat decreased 14 +/- 4% (P < 0.001). There was a 13 +/- 4% decrease in subcutaneous fat (P < 0.01) and a 7 +/- 2% increase in lean muscle mass (P = 0.01) during testosterone therapy. Spinal BMD and trabecular BMD increased by 5 +/- 1% (P < 0.001) and 14 +/- 3% (P < 0.001), respectively. Radial BMD did not change. Serum bone-specific alkaline phosphatase and urinary deoxypyridinoline excretion, markers of bone formation and resorption, respectively, decreased significantly over the 18 months (P = 0.003 and P = 0.04, respectively). We conclude that testosterone therapy given to adult men with acquired hypogonadism decreases sc fat and increases lean muscle mass. In addition, testosterone therapy reduces bone remodeling and increases trabecular bone density. The beneficial effects of androgen administration on body composition and bone density may provide additional indications for testosterone therapy in hypogonadal men.


This article has been cited by other articles:


Home page
 J AndrolHome page
A. M. Traish, A. Guay, R. Feeley, and F. Saad
The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
J Androl, January 1, 2009; 30(1): 10 - 22.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. Callewaert, K. Venken, J. Ophoff, K. De Gendt, A. Torcasio, G. H. van Lenthe, H. Van Oosterwyck, S. Boonen, R. Bouillon, G. Verhoeven, et al.
Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-{alpha}
FASEB J, January 1, 2009; 23(1): 232 - 240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. Misra, D. K Katzman, J. Cord, S. J Manning, D. Mickley, D. B Herzog, K. K Miller, and A. Klibanski
Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents
Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1478 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
D. Rice, R. E. Brannigan, R. K. Campbell, S. Fine, L. Jack Jr, J. B. Nelson, and J. Regan-Klich
Men's Health, Low Testosterone, and Diabetes: Individualized Treatment and a Multidisciplinary Approach
The Diabetes Educator, November 1, 2008; 34(Supplement_5): 97S - 112S.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
R. J. Colman, T. M. Beasley, D. B. Allison, and R. Weindruch
Attenuation of Sarcopenia by Dietary Restriction in Rhesus Monkeys
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 556 - 559.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. A. Swiglo, M. H. Murad, H. J. Schunemann, R. Kunz, R. A. Vigersky, G. H. Guyatt, and V. M. Montori
A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 666 - 673.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. J. Snyder
Might Testosterone Actually Reduce Mortality?
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 32 - 33.
[Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. Brauck, C. J Galban, S. Maderwald, B. L Herrmann, and M. E Ladd
Changes in calf muscle elasticity in hypogonadal males before and after testosterone substitution as monitored by magnetic resonance elastography
Eur. J. Endocrinol., June 1, 2007; 156(6): 673 - 678.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
G.D. Cooper, L.C. Pickavance, J.P.H. Wilding, J.A. HarroLd, J.C.G. HaLford, and A.J. Goudie
Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
J Psychopharmacol, June 1, 2007; 21(4): 405 - 413.
[Abstract] [PDF]

Home page
 Eur J EndocrinolHome page
L. Katznelson, M. W Robinson, C. L Coyle, H. Lee, and C. E Farrell
Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men
Eur. J. Endocrinol., December 1, 2006; 155(6): 867 - 875.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A.-M. Axell, H. E. MacLean, D. R. Plant, L. J. Harcourt, J. A. Davis, M. Jimenez, D. J. Handelsman, G. S. Lynch, and J. D. Zajac
Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E506 - E516.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder, R. S. Swerdloff, and V. M. Montori
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 1995 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller, B. M. K. Biller, C. Beauregard, J. G. Lipman, J. Jones, D. Schoenfeld, J. C. Sherman, B. Swearingen, J. Loeffler, and A. Klibanski
Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1683 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Koranyi, I. Bosaeus, M. Alpsten, B.-A. Bengtsson, and G. Johannsson
Body composition during GH replacement in adults - methodological variations with respect to gender.
Eur. J. Endocrinol., April 1, 2006; 154(4): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. L. Ding, Y. Song, V. S. Malik, and S. Liu
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
JAMA, March 15, 2006; 295(11): 1288 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
J. K. Amory, S. T. Page, and W. J. Bremner
Oral Testosterone in Oil: Pharmacokinetic Effects of 5{alpha} Reduction by Finasteride or Dutasteride and Food Intake in Men
J Androl, January 1, 2006; 27(1): 72 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
E. T. Schroeder, A. F. Vallejo, L. Zheng, Y. Stewart, C. Flores, S. Nakao, C. Martinez, and F. R. Sattler
Six-Week Improvements in Muscle Mass and Strength During Androgen Therapy in Older Men
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1586 - 1592.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Gao, P. J. Reiser, C. C. Coss, M. A. Phelps, J. D. Kearbey, D. D. Miller, and J. T. Dalton
Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized Rats
Endocrinology, November 1, 2005; 146(11): 4887 - 4897.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Aminorroaya, S. Kelleher, A. J Conway, L. P Ly, and D. J Handelsman
Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men
Eur. J. Endocrinol., June 1, 2005; 152(6): 881 - 886.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. K. Amory and W. J. Bremner
Oral Testosterone in Oil Plus Dutasteride in Men: A Pharmacokinetic Study
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2610 - 2617.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. T. Page, J. K. Amory, F. D. Bowman, B. D. Anawalt, A. M. Matsumoto, W. J. Bremner, and J. L. Tenover
Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1502 - 1510.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller, K. A. Grieco, and A. Klibanski
Testosterone Administration in Women with Anorexia Nervosa
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1428 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Jasuja, P. Ramaraj, R. P. Mac, A. B. Singh, T. W. Storer, J. Artaza, A. Miller, R. Singh, W. E. Taylor, M. L. Lee, et al.
{Delta}-4-Androstene-3,17-Dione Binds Androgen Receptor, Promotes Myogenesis in Vitro, and Increases Serum Testosterone Levels, Fat-Free Mass, and Muscle Strength in Hypogonadal Men
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 855 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism
Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. T. Schroeder, L. Zheng, M. D. Ong, C. Martinez, C. Flores, Y. Stewart, C. Azen, and F. R. Sattler
Effects of Androgen Therapy on Adipose Tissue and Metabolism in Older Men
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4863 - 4872.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
I. Sinha-Hikim, W. E. Taylor, N. F. Gonzalez-Cadavid, W. Zheng, and S. Bhasin
Androgen Receptor in Human Skeletal Muscle and Cultured Muscle Satellite Cells: Up-Regulation by Androgen Treatment
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5245 - 5255.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. R. Smith, M. Goode, A. L. Zietman, F. J. McGovern, H. Lee, and J. S. Finkelstein
Bicalutamide Monotherapy Versus Leuprolide Monotherapy for Prostate Cancer: Effects on Bone Mineral Density and Body Composition
J. Clin. Oncol., July 1, 2004; 22(13): 2546 - 2553.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson
Androgens and Bone
Endocr. Rev., June 1, 2004; 25(3): 389 - 425.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Wang, G. Cunningham, A. Dobs, A. Iranmanesh, A. M. Matsumoto, P. J. Snyder, T. Weber, N. Berman, L. Hull, and R. S. Swerdloff
Long-Term Testosterone Gel (AndroGel) Treatment Maintains Beneficial Effects on Sexual Function and Mood, Lean and Fat Mass, and Bone Mineral Density in Hypogonadal Men
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2085 - 2098.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Asthana, S. Bhasin, R. N. Butler, H. Fillit, J. Finkelstein, S. M. Harman, L. Holstein, S. G. Korenman, A. M. Matsumoto, J. E. Morley, et al.
Masculine Vitality: Pros and Cons of Testosterone in Treating the Andropause
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): M461 - M465.
[Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. T. Schroeder, L. Zheng, K. E. Yarasheski, D. Qian, Y. Stewart, C. Flores, C. Martinez, M. Terk, and F. R. Sattler
Treatment with oxandrolone and the durability of effects in older men
J Appl Physiol, March 1, 2004; 96(3): 1055 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 Am J Sports MedHome page
N. A. Evans
Current Concepts in Anabolic-Androgenic Steroids
Am. J. Sports Med., March 1, 2004; 32(2): 534 - 542.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. K. Amory, N. B. Watts, K. A. Easley, P. R. Sutton, B. D. Anawalt, A. M. Matsumoto, W. J. Bremner, and J. L. Tenover
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 503 - 510.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Mayo, H. Macintyre, A. M. Wallace, and S. F. Ahmed
Transdermal Testosterone Application: Pharmacokinetics and Effects on Pubertal Status, Short-Term Growth, and Bone Turnover
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 681 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. J. Woodhouse, N. Gupta, M. Bhasin, A. B. Singh, R. Ross, J. Phillips, and S. Bhasin
Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 718 - 726.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Bhasin, W. E. Taylor, R. Singh, J. Artaza, I. Sinha-Hikim, R. Jasuja, H. Choi, and N. F. Gonzalez-Cadavid
The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1103 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Moverare, K. Venken, A.-L. Eriksson, N. Andersson, S. Skrtic, J. Wergedal, S. Mohan, P. Salmon, R. Bouillon, J.-A. Gustafsson, et al.
Differential effects on bone of estrogen receptor {alpha} and androgen receptor activation in orchidectomized adult male mice
PNAS, November 11, 2003; 100(23): 13573 - 13578.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee
Endogenous Sex Hormones and Cardiovascular Disease in Men
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Bhasin
Testosterone Supplementation for Aging-Associated Sarcopenia
J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2003; 58(11): M1002 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
J. K. Amory, G. K. E. Scriba, D. W. Amory, and W. J. Bremner
Oral Testosterone-Triglyceride Conjugate in Rabbits: Single-Dose Pharmacokinetics and Comparison With Oral Testosterone Undecanoate
J Androl, September 1, 2003; 24(5): 716 - 720.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Svartberg, R. Jorde, J. Sundsfjord, K. H. Bonaa, and E. Barrett-Connor
Seasonal Variation of Testosterone and Waist to Hip Ratio in Men: The Tromso Study
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3099 - 3104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Sinha-Hikim, S. M. Roth, M. I. Lee, and S. Bhasin
Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E197 - E205.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. A. Anderson, A. M. Wallace, N. Sattar, N. Kumar, and K. Sundaram
Evidence for Tissue Selectivity of the Synthetic Androgen 7{alpha}-Methyl-19-Nortestosterone in Hypogonadal Men
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2784 - 2793.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Svensson, K. Stibrant Sunnerhagen, and G. Johannsson
Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2061 - 2069.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
S. Bhasin, A. B. Singh, R. P. Mac, B. Carter, M. I. Lee, and G. R. Cunningham
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
J Androl, May 1, 2003; 24(3): 299 - 311.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. J. Woodhouse, S. Reisz-Porszasz, M. Javanbakht, T. W. Storer, M. Lee, H. Zerounian, and S. Bhasin
Development of models to predict anabolic response to testosterone administration in healthy young men
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1009 - E1017.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. C. W. Wu and A. von Eckardstein
Androgens and Coronary Artery Disease
Endocr. Rev., April 1, 2003; 24(2): 183 - 217.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. W. Storer, L. Magliano, L. Woodhouse, M. L. Lee, C. Dzekov, J. Dzekov, R. Casaburi, and S. Bhasin
Testosterone Dose-Dependently Increases Maximal Voluntary Strength and Leg Power, but Does Not Affect Fatigability or Specific Tension
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1478 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Benito, B. Gomberg, F. W. Wehrli, R. H. Weening, B. Zemel, A. C. Wright, H. K. Song, A. Cucchiara, and P. J. Snyder
Deterioration of Trabecular Architecture in Hypogonadal Men
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1497 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
P. G Clay and A. I Lam
Testosterone Replacement Therapy for Bone Loss Prevention in HIV-Infected Males
Ann. Pharmacother., April 1, 2003; 37(4): 582 - 585.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. L. Herbst, B. D. Anawalt, J. K. Amory, A. M. Matsumoto, and W. J. Bremner
The Male Contraceptive Regimen of Testosterone and Levonorgestrel Significantly Increases Lean Mass in Healthy Young Men in 4 Weeks, but Attenuates a Decrease in Fat Mass Induced by Testosterone Alone
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1167 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. T. Schroeder, A. Singh, S. Bhasin, T. W. Storer, C. Azen, T. Davidson, C. Martinez, I. Sinha-Hikim, S. V. Jaque, M. Terk, et al.
Effects of an oral androgen on muscle and metabolism in older, community-dwelling men
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E120 - E128.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. M. Kenny, K. M. Prestwood, C. A. Gruman, G. Fabregas, B. Biskup, and G. Mansoor
Effects of Transdermal Testosterone on Lipids and Vascular Reactivity in Older Men With Low Bioavailable Testosterone Levels
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2002; 57(7): M460 - 465.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Sinha-Hikim, J. Artaza, L. Woodhouse, N. Gonzalez-Cadavid, A. B. Singh, M. I. Lee, T. W. Storer, R. Casaburi, R. Shen, and S. Bhasin
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E154 - E164.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. K. Miller, B. M. K. Biller, J. Hier, E. Arena, and A. Klibanski
Androgens and Bone Density in Women with Hypopituitarism
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2770 - 2776.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. Tamaya-Mori, K. Uemura, and A. Iguchi
Gender Differences in the Dietary Lard-Induced Increase in Blood Pressure in Rats
Hypertension, May 1, 2002; 39(5): 1015 - 1020.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Smith, J. S. Finkelstein, F. J. McGovern, A. L. Zietman, M. A. Fallon, D. A. Schoenfeld, and P. W. Kantoff
Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 599 - 603.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
A. M. Matsumoto
Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99.
[Full Text]